ES2122085T3 - Combinacion antibiotica. - Google Patents

Combinacion antibiotica.

Info

Publication number
ES2122085T3
ES2122085T3 ES94108767T ES94108767T ES2122085T3 ES 2122085 T3 ES2122085 T3 ES 2122085T3 ES 94108767 T ES94108767 T ES 94108767T ES 94108767 T ES94108767 T ES 94108767T ES 2122085 T3 ES2122085 T3 ES 2122085T3
Authority
ES
Spain
Prior art keywords
antibiotic combination
antibiotic
combination
epiroprim
dapsone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94108767T
Other languages
English (en)
Inventor
Ivan Kompis
Rudolf Then
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2122085T3 publication Critical patent/ES2122085T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A PREPARADOS FARMACEUTICOS, CONTENIENDO EPIROPRIM Y DAPSON, QUE PUEDEN SER UTILIZADOS PARA EL TRATAMIENTO DE INFECCIONES CON EXCITACION MICROBARTERIANA, ACTINOMICETOS Y TOXOPLASMOSIS.
ES94108767T 1993-06-17 1994-06-08 Combinacion antibiotica. Expired - Lifetime ES2122085T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH180193 1993-06-17

Publications (1)

Publication Number Publication Date
ES2122085T3 true ES2122085T3 (es) 1998-12-16

Family

ID=4218921

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94108767T Expired - Lifetime ES2122085T3 (es) 1993-06-17 1994-06-08 Combinacion antibiotica.

Country Status (13)

Country Link
US (1) US5721242A (es)
EP (1) EP0629403B1 (es)
JP (1) JP2650852B2 (es)
CN (1) CN1054745C (es)
AT (1) ATE170751T1 (es)
AU (1) AU685449B2 (es)
CA (1) CA2125121A1 (es)
DE (1) DE59406863D1 (es)
DK (1) DK0629403T3 (es)
ES (1) ES2122085T3 (es)
MY (1) MY110998A (es)
NZ (1) NZ260721A (es)
RU (1) RU2136272C1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2030129A1 (en) * 1989-11-29 1991-05-30 Thomas Saupe 1,8-napthalenedicarboximides as antidotes
DK1280796T3 (da) * 2000-04-27 2004-08-02 Basilea Pharmaceutica Ag Pyrimidinyl-methyl-indol-derivater med antibakteriel aktivitet
WO2005016296A1 (en) * 2003-08-13 2005-02-24 Qlt Usa, Inc. Emulsive composition containing dapsone
RU2297839C1 (ru) * 2005-10-10 2007-04-27 Всероссийский научно-исследовательский институт пантового оленеводства (ВНИИПО) Лекарственное средство для лечения актиномикоза
CN102271693B (zh) * 2009-01-12 2013-11-06 英特威国际有限公司 保护动物对抗由属于诺卡氏菌型放线菌组的细菌感染引起的疾病的药物组合物
MX2009004635A (es) * 2009-04-29 2010-10-29 Univ Autonoma Metropolitana Formas farmaceúticas solubles de la n,n´-diamino-difenilsulfona para su uso óptimo en el tratamiento de diversas enfermedades.
RU2426533C1 (ru) * 2010-02-08 2011-08-20 Федеральное государственное учреждение "Научно-исследовательский институт по изучению лепры Федерального агентства по здравоохранению и социальному развитию" Способ коррекции анемии, вызываемой введением препарата дапсон, в эксперименте
RU2638926C2 (ru) * 2016-06-02 2017-12-19 федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации Противолепрозное средство, обладающее бактериостатической и бактерицидной активностью в отношении m. lufu, представляющее собой производное o-бензоиламинобензойной кислоты
JP7446594B2 (ja) * 2017-07-21 2024-03-11 学校法人東京薬科大学 好中球細胞外トラップ形成促進剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
ATE15446T1 (de) * 1981-09-23 1985-09-15 Hoffmann La Roche Verfahren zur herstellung von sulfonamidpotentiator-l¯sungenund ein neues sulfanilamid.
US4590271A (en) * 1982-05-01 1986-05-20 Burroughs Wellcome Co. 2,4-diamino-5-(substituted)pyrimidines, useful as antimicrobials
US4587341A (en) * 1982-05-07 1986-05-06 Burroughs Wellcome Co. 2,4-diamino-5-(1,2,3,4-tetrahydro-(substituted or unsubstituted)-6-quinolylmethyl)pyrimidines, useful as antimicrobials
EP0639075A1 (en) * 1990-11-14 1995-02-22 Chiron Corporation Specific inhibition of dihydrofolate reductase and compounds therefor

Also Published As

Publication number Publication date
CA2125121A1 (en) 1994-12-18
AU685449B2 (en) 1998-01-22
US5721242A (en) 1998-02-24
AU6469794A (en) 1994-12-22
DE59406863D1 (de) 1998-10-15
MY110998A (en) 1999-07-31
RU2136272C1 (ru) 1999-09-10
EP0629403B1 (de) 1998-09-09
DK0629403T3 (da) 1999-06-07
RU94019991A (ru) 1996-04-27
ATE170751T1 (de) 1998-09-15
JP2650852B2 (ja) 1997-09-10
EP0629403A1 (de) 1994-12-21
JPH072672A (ja) 1995-01-06
NZ260721A (en) 1997-03-24
CN1054745C (zh) 2000-07-26
CN1105563A (zh) 1995-07-26

Similar Documents

Publication Publication Date Title
DE3679971D1 (de) Modulationsdotierter feldeffekttransistor.
DE69009436D1 (de) Selektive Adsorption von Stickstoff auf Magnesium enthaltende Clinoptilolite.
ES2056963T3 (es) Agentes antibacterianos.
ES2051768T3 (es) Compuestos farmaceuticos mejorados con contenido de metales.
DE69319976D1 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
MX9300766A (es) Piridonas sustituidas por sulfonilbencilo, procedimiento para su obtencion y medicamentos que las contienen.
FI945835L (fi) Dispersioita ja liuoksia, jotka sisältävät hydroksyyliamiiniyhdisteitä silloitusaineina
FI962483L (fi) Menetelmät ja materiaalit Staphylococcus aureusin detektoimiseksi
DE68901415D1 (de) Antibiotikum.
ES2122085T3 (es) Combinacion antibiotica.
GR3006180T3 (es)
ES2129397T3 (es) Derivados heteroaroilo de antibioticos beta-lactamas monociclicos.
UA32522C2 (uk) Ліофілізована протипухлинна композиція і стерильна водна композиція для ін'єкцій на її основі
PT100914A (pt) Uso de compostos capazes de sofrer uma permuta mista com dissulfureto, com uma ligacao dissulfureto, no tratamento de infeccao por hiv
EP0639331A3 (en) Fumigants.
FI875353A0 (fi) Cytostatiskt verkande antracyklinderivat.
SE7603165L (sv) Antibiotikum
NL192926B (nl) Cefalosporinederivaat met antibacteriële werking, en farmaceutisch preparaat daaruit.
IT8019645A0 (it) Antibiotico e procedimento microbiologico per produrlo.
DK0579939T3 (da) Phospholipidderivater
DE68920104D1 (de) Polyolefin-Zusammensetzungen und deren Anwendungen.
FI854708A0 (fi) Organisk foerening, mikrobiologiskt foerfarande foer dess framstaellning samt dess anvaendning.
ES491626A0 (es) Perfeccionamientos introducidos en las puertas logicas de transistores.
ES2019583B3 (es) Composicion para el tratamiento de infecciones.
BR7301812D0 (pt) Composicao pesticida,especialmente fungicida e bactericidacomposicao pesticida, especialmente fungicida e bactericid e processo de combate de pragas,especialmente fungos ou ba e processo de combate de pragas,especialmente fungos ou acterias bacterias

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 629403

Country of ref document: ES